Lakatos Bálint Károly, Ladányi Zsuzsanna, Fábián Alexandra, Ehrenberger Réka, Turschl Tímea, Bagyura Zsolt, Evrard Bruno, Vandroux David, Goudelin Marine, Lindner Simon, Britsch Simone, Dürschmied Daniel, Zima Endre, Csikós Gergely Richárd, Túróczi Zsolt, Soltész Ádám, Németh Endre, Kovács Attila, Édes Ferenc István, Merkely Béla
Heart and Vascular Center, Semmelweis University, Budapest, Hungary.
Medical-Surgical ICU, Dupuytren Teaching Hospital, Limoges, France.
Front Cardiovasc Med. 2024 May 28;11:1399874. doi: 10.3389/fcvm.2024.1399874. eCollection 2024.
Veno-arterial extracorporeal membrane oxygenation (VA-ECMO) is an increasingly utilized therapeutic choice in patients with cardiogenic shock, however, high complication rate often counteracts with its beneficial cardiopulmonary effects. The assessment of left ventricular (LV) function in key in the management of this population, however, the most commonly used measures of LV performance are substantially load-dependent. Non-invasive myocardial work is a novel LV functional measure which may overcome this limitation and estimate LV function independent of the significantly altered loading conditions of VA-ECMO therapy. The Usefulness of Myocardial Work IndeX in ExtraCorporeal Membrane Oxygenation Patients (MIX-ECMO) study aims to examine the prognostic role of non-invasive myocardial work in VA-ECMO-supported patients.
The MIX-ECMO is a multicentric, prospective, observational study. We aim to enroll 110 patients 48-72 h after the initiation of VA-ECMO support. The patients will undergo a detailed echocardiographic examination and a central echocardiography core laboratory will quantify conventional LV functional measures and non-invasive myocardial work parameters. The primary endpoint will be failure to wean at 30 days as a composite of cardiovascular mortality, need for long-term mechanical circulatory support or heart transplantation at 30 days, and besides that other secondary objectives will also be investigated. Detailed clinical data will also be collected to compare LV functional measures to parameters with established prognostic role and also to the Survival After Veno-arterial-ECMO (SAVE) score.
The MIX-ECMO study will be the first to determine if non-invasive myocardial work has added prognostic value in patients receiving VA-ECMO support.
静脉-动脉体外膜肺氧合(VA-ECMO)在心源休克患者中的应用越来越广泛,然而,高并发症发生率往往抵消了其有益的心肺效应。评估左心室(LV)功能是管理这类患者的关键,然而,最常用的左心室功能指标很大程度上依赖于负荷。无创心肌功是一种新的左心室功能指标,它可能克服这一局限性,并能在VA-ECMO治疗负荷条件显著改变的情况下独立评估左心室功能。体外膜肺氧合患者心肌功指数的实用性(MIX-ECMO)研究旨在探讨无创心肌功在接受VA-ECMO支持患者中的预后作用。
MIX-ECMO是一项多中心、前瞻性、观察性研究。我们的目标是在启动VA-ECMO支持后48-72小时纳入110例患者。患者将接受详细的超声心动图检查,一个中央超声心动图核心实验室将对传统的左心室功能指标和无创心肌功参数进行量化。主要终点将是30天时脱机失败,定义为心血管死亡、30天时需要长期机械循环支持或心脏移植的综合情况,除此之外,还将研究其他次要目标。还将收集详细的临床数据,以比较左心室功能指标与具有既定预后作用的参数,以及与静脉-动脉体外膜肺氧合后生存率(SAVE)评分。
MIX-ECMO研究将首次确定无创心肌功在接受VA-ECMO支持的患者中是否具有额外的预后价值。